)
Visual24 Oct 2025
The rise of Alphabet
Iconovo (ICO) investor relations material
Iconovo Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary24 Oct, 2025
Executive summary
Major reorganization in Q3 2025 to focus on ICOpre, ICOres, and intranasal semaglutide development.
Board and largest shareholders unanimously support the new strategic direction.
Cost base significantly reduced, with further decreases expected in Q4 2025.
Previous financial targets withdrawn in October 2025; new targets to be set.
Financial highlights
Net sales for Q3 2025 were TSEK 7, up from TSEK 0 in Q3 2024; Jan–Sep 2025 net sales were TSEK 601, down from TSEK 1,948 year-over-year.
Operating loss for Q3 2025 was TSEK -8,828, improved from TSEK -11,080 in Q3 2024.
Loss for Jan–Sep 2025 was TSEK -30,396, nearly unchanged from TSEK -30,302 last year.
Cash and cash equivalents at period end were TSEK 18,550, up from TSEK 8,912 a year earlier.
Shareholders' equity increased to TSEK 130,711 from TSEK 111,700 year-over-year.
Outlook and guidance
New financial and strategic targets will be presented after a review, focusing on value optimization and commercialization of inhalers and semaglutide nasal product.
Financing for operations and plans is secured for the next 12 months based on current outlook and cost reductions.
How will the new business model impact long-term revenue?
What is the timeline for semaglutide in vivo studies?
What is the expected Q4 cost reduction magnitude?
What is the capital call's purpose?
Describe game-changing quality efforts
What is the generic product strategy?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Iconovo earnings date
Q4 202527 Feb, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Iconovo AB develops and licenses inhalation devices for inhaled medicine. The company’s product portfolio includes the Icon, a disposable handheld inhaler, which is a solution for respiratory diseases; Clickhaler, a drug delivery inhaler that is used to treat respiratory airways inflammation and asthma; and Easyhaler, a powder inhaler that is used for the treatment of asthma and chronic obstructive pulmonary disease.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage